Zhang, Wei

Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans

Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., et al. (2009) · Journal of Clinical Investigation

Diet, Metabolism, and DiseaseLiver Disease Diagnosis and Treatment

Cited by 1,765

The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer

Zhang, L., Li, Y., Wang, Q., Chen, Z., Li, X., Wu, Z., Hu, C., Liao, D., Zhang, W., & Chen, Z.-S. (2020) · Molecular Cancer

Drug Transport and Resistance MechanismsPI3K/AKT/mTOR signaling in cancer

Cited by 152

Caloric restriction increases ketone bodies metabolism and preserves blood flow in aging brain

Lin, A.-L., Zhang, W., Gao, X., & Watts, L. (2015) · Neurobiology of Aging

Genetics, Aging, and Longevity in Model OrganismsDietary Effects on Health

Cited by 90

Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis: Metformin vs thiazolidinediones for PCOS

Li, X.-J., Yu, Y.-X., Liu, C.-Q., Zhang, W., Zhang, H.-J., Yan, B., Wang, L.-Y., Yang, S.-Y., & Zhang, S.-H. (2011) · Clinical Endocrinology

Ovarian function and disordersDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 67

Targeting mTOR signaling overcomes acquired resistance to combined BRAF and MEK inhibition in BRAF-mutant melanoma

Wang, B., Zhang, W., Zhang, G., Kwong, L., Lu, H., Tan, J., Sadek, N., Xiao, M., Zhang, J., Labrie, M., et al. (2021) · Oncogene

Melanoma and MAPK PathwaysPI3K/AKT/mTOR signaling in cancer

Cited by 66

Short-term systolic blood pressure variability and kidney disease progression in patients with chronic kidney disease: results from C-STRIDE

Wang, Q., Wang, Y., Wang, J., Zhang, L., Zhao, M., Wang, X., Yuan, J., Zhou, Q., Yuan, Q., Chen, M., et al. (2020) · Journal of the American Heart Association

Blood Pressure and Hypertension StudiesChronic Kidney Disease and Diabetes

Cited by 24

Bupropion Treatment of Olanzapine-Associated Weight Gain: An Open-Label, Prospective Trial

Gadde, K. M., Zhang, W., & Foust, M. S. (2006) · Journal of Clinical Psychopharmacology

Schizophrenia research and treatmentPharmacology and Obesity Treatment

Cited by 24